- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-904X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Population Pharmacokinetics and Exposure-Response Relationships of Naldemedine ; volume:35 ; number:11 ; day:2 ; month:10 ; year:2018 ; pages:1-11 ; date:11.2018
Pharmaceutical research ; 35, Heft 11 (2.10.2018), 1-11, 11.2018
- Creator
-
Kubota, Ryuji
Fukumura, Kazuya
Wajima, Toshihiro
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11095-018-2501-7
- URN
-
urn:nbn:de:101:1-2018121923143936177880
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kubota, Ryuji
- Fukumura, Kazuya
- Wajima, Toshihiro
- SpringerLink (Online service)
Other Objects (12)
Upadacitinib Population Pharmacokinetics and Exposure-Response Relationships in Ulcerative Colitis Patients
Population pharmacokinetics and exposure–response relationships of maribavir in transplant recipients with cytomegalovirus infection
Population Pharmacokinetics and Exposure–Response Analyses for Risankizumab in Patients with Active Psoriatic Arthritis
Pharmacokinetics and Exposure–Response of Vosoritide in Children with Achondroplasia
Population Pharmacokinetics and Exposure–Response (Efficacy and Safety/Tolerability) of Empagliflozin in Patients with Type 2 Diabetes
Population pharmacokinetics and exposure–response modeling and simulation for evolocumab in healthy volunteers and patients with hypercholesterolemia
Population Pharmacokinetics, Efficacy Exposure-response Analysis, and Model-based Meta-analysis of Fenebrutinib in Subjects with Rheumatoid Arthritis
Trend tests for the evaluation of exposure-response relationships in epidemiological exposure studies
Population Pharmacokinetics and Exposure–Response with Teclistamab in Patients With Relapsed/Refractory Multiple Myeloma: Results From MajesTEC-1
Effect of ethnicity on vinorelbine pharmacokinetics: a population pharmacokinetics analysis
Population Pharmacokinetics and Exposure–Response Analysis for the Phase 3 COSMIC-311 Trial of Cabozantinib for Radioiodine-Refractory Differentiated Thyroid Cancer
Population-Based Exposure-Response Modeling for Hand-Arm Vibration
Upadacitinib Population Pharmacokinetics and Exposure-Response Relationships in Ulcerative Colitis Patients
Population pharmacokinetics and exposure–response relationships of maribavir in transplant recipients with cytomegalovirus infection
Population Pharmacokinetics and Exposure–Response Analyses for Risankizumab in Patients with Active Psoriatic Arthritis
Pharmacokinetics and Exposure–Response of Vosoritide in Children with Achondroplasia
Population Pharmacokinetics and Exposure–Response (Efficacy and Safety/Tolerability) of Empagliflozin in Patients with Type 2 Diabetes
Population pharmacokinetics and exposure–response modeling and simulation for evolocumab in healthy volunteers and patients with hypercholesterolemia
Population Pharmacokinetics, Efficacy Exposure-response Analysis, and Model-based Meta-analysis of Fenebrutinib in Subjects with Rheumatoid Arthritis
Trend tests for the evaluation of exposure-response relationships in epidemiological exposure studies
Population Pharmacokinetics and Exposure–Response with Teclistamab in Patients With Relapsed/Refractory Multiple Myeloma: Results From MajesTEC-1
Effect of ethnicity on vinorelbine pharmacokinetics: a population pharmacokinetics analysis
Population Pharmacokinetics and Exposure–Response Analysis for the Phase 3 COSMIC-311 Trial of Cabozantinib for Radioiodine-Refractory Differentiated Thyroid Cancer
Population-Based Exposure-Response Modeling for Hand-Arm Vibration
Upadacitinib Population Pharmacokinetics and Exposure-Response Relationships in Ulcerative Colitis Patients
Population pharmacokinetics and exposure–response relationships of maribavir in transplant recipients with cytomegalovirus infection
Population Pharmacokinetics and Exposure–Response Analyses for Risankizumab in Patients with Active Psoriatic Arthritis
Pharmacokinetics and Exposure–Response of Vosoritide in Children with Achondroplasia
Population Pharmacokinetics and Exposure–Response (Efficacy and Safety/Tolerability) of Empagliflozin in Patients with Type 2 Diabetes
Population pharmacokinetics and exposure–response modeling and simulation for evolocumab in healthy volunteers and patients with hypercholesterolemia
Population Pharmacokinetics, Efficacy Exposure-response Analysis, and Model-based Meta-analysis of Fenebrutinib in Subjects with Rheumatoid Arthritis
Trend tests for the evaluation of exposure-response relationships in epidemiological exposure studies
Population Pharmacokinetics and Exposure–Response with Teclistamab in Patients With Relapsed/Refractory Multiple Myeloma: Results From MajesTEC-1
Effect of ethnicity on vinorelbine pharmacokinetics: a population pharmacokinetics analysis
Population Pharmacokinetics and Exposure–Response Analysis for the Phase 3 COSMIC-311 Trial of Cabozantinib for Radioiodine-Refractory Differentiated Thyroid Cancer